The update of the Guide for the management of patients with HIV/AIDS originated a new conflict between authorities of the National Center for the prevention and Control of HIV/AIDS (Censida) and civil society organizations. The argument of regulating, to optimize the use of available financial resources and avoid that doctors keep prescribing without any supervision, the Agency under the Ministry of health (Ssa) issued a document of mandatory application in the public sector, which limits to three the number of therapeutic alternatives for carriers of the virus that first require medical treatment.
For groupings of civil society is an arbitrary act that only seeks to saving money at the expense of the qualityof the attention that they deserve the HIV-positive. In addition, said at a protest in front of the Ssa, the new guide as services and limits the freedom of doctors prescription, because it raises a different therapeutic option must be approved by institutional committees, which exist only in the Mexican Social Security Institute (IMSS).
On behalf of more than 30 groups of various States of the Republic, Luis Adrián Quiroz, dependants living with HIV, the IMSS, said that the new guide lacks the support of especialistas until 2008 it had to charge the elaboration of the guidelines for the clinical care of the condition; In addition, therapies that do not consider the diversity of situations that may present disease and patients.
In a letter to the Secretary of health, Salomon Chertorivski, the protesters denounced that "there seems to be corruption", as as alternative to a second line of treatment is privileged a drug developed by a laboratory (Abbott) that recently it has funded Census programs.
The activists mentioned that unlike previous guidelines, this new proposal for a census, which the authors are not identified nor includes essential information on the clinical patterns in cases of people who have therapeutic failure; do not speak of opportunistic infections and their treatment, nor of co-infections such as hepatitis B, C and tuberculosis, among others.
Quiroz recalled that he was part of the working group responsible for the development of the Guide, whose last update was done in 2010, but census "never published it and the work was there. Now, without informing anyone emits a new document without any explanation". He said that any proposal should be endorsed by the National Council for the Control of AIDS (Conasida), which is not complete, because not have elected representatives of civil society.
In this regard, Carmen Soler, researcher of the Institute of research biomedical of the University national autonomous of Mexico, participant in the elaboration of the new guidelines for the management of HIV/AIDS, said that the restriction of therapies is a practice recommended by the World Health Organization as a public policy; but, he said, in Mexico will apply only to new patients, with the aim that in the course of five to six years to achieve rationalization of recipes of antiretrovirals.
The specialist recognized that the application of the new guide will be formalized until the institutional committees responsible for resolving situations of emergency, which will happen soon, because April 15 census will issue the call to specialists interested in being part of those bodies have been created.